Related references
Note: Only part of the references are listed.Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial
Gary P. Wang et al.
BLOOD (2010)
Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates
Brian C. Beard et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy
Eugenio Montini et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Genotoxic Potential of Lineage-specific Lentivirus Vectors Carrying the β-Globin Locus Control Region
Paritha I. Arumugam et al.
MOLECULAR THERAPY (2009)
Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors
Ute Modlich et al.
MOLECULAR THERAPY (2009)
Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoletic stem cells
Michael D. Milsom et al.
CANCER RESEARCH (2008)
Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin
Olivier Negre et al.
EXPERIMENTAL HEMATOLOGY (2008)
DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer
Gary P. Wang et al.
NUCLEIC ACIDS RESEARCH (2008)
HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications
Gary P. Wang et al.
GENOME RESEARCH (2007)
A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase
K. Cornetta et al.
CANCER GENE THERAPY (2006)
Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP)
AW Gross et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptor
F Urbinati et al.
HUMAN GENE THERAPY (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
G Puthenveetil et al.
BLOOD (2004)
Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells
S Imren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Correction of phenotype in a thalassemia mouse model using a nonmyeloablative marrow transplantation regimen
MB Bradley et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Correction of sickle cell disease in transgenic mouse models by gene therapy
R Pawliuk et al.
SCIENCE (2001)
High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors
F Moreau-Gaudry et al.
BLOOD (2001)
Increased cell surface expression of C-terminal truncated erythropoietin receptors in polycythemia
T Motohashi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2001)
Functional requirements for phenotypic correction of murine β-thalassemia:: implications for human gene therapy
DA Persons et al.
BLOOD (2001)
Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin
C May et al.
NATURE (2000)
Long-term survive of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation
M Andreani et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
